16:24:01 Europe / Stockholm

Bifogade filer

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Kalender

2024-10-18 Kvartalsrapport 2024-Q3
2024-07-18 Kvartalsrapport 2024-Q2
2024-04-23 Ordinarie utdelning GETI B 4.40 SEK
2024-04-22 Årsstämma 2024
2024-04-22 Kvartalsrapport 2024-Q1
2024-02-01 Bokslutskommuniké 2023
2023-10-23 Kvartalsrapport 2023-Q3
2023-07-18 Kvartalsrapport 2023-Q2
2023-04-27 Ordinarie utdelning GETI B 4.25 SEK
2023-04-26 Årsstämma 2023
2023-04-26 Kvartalsrapport 2023-Q1
2023-02-01 Bokslutskommuniké 2022
2022-10-19 Kvartalsrapport 2022-Q3
2022-07-19 Kvartalsrapport 2022-Q2
2022-04-27 Ordinarie utdelning GETI B 4.00 SEK
2022-04-26 Kvartalsrapport 2022-Q1
2022-04-26 Årsstämma 2022
2022-01-28 Bokslutskommuniké 2021
2021-10-20 Kvartalsrapport 2021-Q3
2021-07-16 Kvartalsrapport 2021-Q2
2021-04-21 Ordinarie utdelning GETI B 3.00 SEK
2021-04-20 Kvartalsrapport 2021-Q1
2021-04-20 Årsstämma 2021
2021-01-28 Bokslutskommuniké 2020
2020-10-16 Kvartalsrapport 2020-Q3
2020-07-16 Kvartalsrapport 2020-Q2
2020-06-29 Ordinarie utdelning GETI B 1.50 SEK
2020-06-26 Årsstämma 2020
2020-04-22 Kvartalsrapport 2020-Q1
2020-01-30 Bokslutskommuniké 2019
2019-10-18 Kvartalsrapport 2019-Q3
2019-07-17 Kvartalsrapport 2019-Q2
2019-04-24 Ordinarie utdelning GETI B 1.00 SEK
2019-04-23 Årsstämma 2019
2019-04-23 Kvartalsrapport 2019-Q1
2019-01-30 Bokslutskommuniké 2018
2018-10-18 Kvartalsrapport 2018-Q3
2018-07-17 Kvartalsrapport 2018-Q2
2018-04-27 Ordinarie utdelning GETI B 1.50 SEK
2018-04-26 Årsstämma 2018
2018-04-26 Kvartalsrapport 2018-Q1
2018-01-29 Bokslutskommuniké 2017
2017-10-18 Kvartalsrapport 2017-Q3
2017-07-17 Kvartalsrapport 2017-Q2
2017-04-25 Kvartalsrapport 2017-Q1
2017-03-30 Ordinarie utdelning GETI B 2.00 SEK
2017-03-29 Årsstämma 2017
2017-01-26 Bokslutskommuniké 2016
2016-10-18 Kvartalsrapport 2016-Q3
2016-07-14 Kvartalsrapport 2016-Q2
2016-04-22 Kvartalsrapport 2016-Q1
2016-03-31 Ordinarie utdelning
2016-03-30 Årsstämma 2016
2016-01-28 Bokslutskommuniké 2015
2015-10-15 Kvartalsrapport 2015-Q3
2015-09-02 Extra Bolagsstämma 2015
2015-07-15 Kvartalsrapport 2015-Q2
2015-04-20 Kvartalsrapport 2015-Q1
2015-03-26 Ordinarie utdelning GETI B 2.80 SEK
2015-03-25 Årsstämma 2015
2015-01-28 Bokslutskommuniké 2014
2014-10-16 Kvartalsrapport 2014-Q3
2014-10-16 Analytiker möte 2014
2014-07-15 Kvartalsrapport 2014-Q2
2014-04-16 Kvartalsrapport 2014-Q1
2014-03-21 Ordinarie utdelning GETI B 4.15 SEK
2014-03-20 Årsstämma 2014
2014-01-28 Bokslutskommuniké 2013
2013-10-15 Analytiker möte 2013
2013-10-15 15-7 2013
2013-10-15 Kvartalsrapport 2013-Q3
2013-07-11 Kvartalsrapport 2013-Q2
2013-04-17 Kvartalsrapport 2013-Q1
2013-03-22 Ordinarie utdelning GETI B 4.15 SEK
2013-03-21 Årsstämma 2013
2013-02-08 Kapitalmarknadsdag 2013
2013-01-25 Bokslutskommuniké 2012
2012-10-17 Analytiker möte 2012
2012-10-17 Kvartalsrapport 2012-Q3
2012-07-11 Kvartalsrapport 2012-Q2
2012-04-19 Kvartalsrapport 2012-Q1
2012-03-29 Ordinarie utdelning GETI B 3.75 SEK
2012-03-28 Årsstämma 2012
2012-01-26 Bokslutskommuniké 2011
2011-10-20 Kvartalsrapport 2011-Q3
2011-07-11 Kvartalsrapport 2011-Q2
2011-04-28 Ordinarie utdelning GETI B 3.25 SEK
2011-04-27 Kvartalsrapport 2011-Q1
2011-04-27 Årsstämma 2011
2011-01-28 Kapitalmarknadsdag 2011
2011-01-26 Bokslutskommuniké 2010
2010-10-19 Kvartalsrapport 2010-Q3
2010-04-23 Ordinarie utdelning GETI B 2.75 SEK
2010-04-22 Ordinarie utdelning GETI B 2.75 SEK
2010-04-21 Årsstämma 2010
2010-04-21 Kvartalsrapport 2010-Q1
2010-01-26 Bokslutskommuniké 2009
2009-07-13 Kvartalsrapport 2009-Q2
2009-05-06 Kvartalsrapport 2009-Q3
2009-04-22 Ordinarie utdelning GETI B 2.40 SEK
2009-04-21 Årsstämma 1
2009-04-21 Kvartalsrapport 2009-Q1
2008-04-18 Ordinarie utdelning GETI B 2.40 SEK
2007-04-20 Ordinarie utdelning GETI B 2.20 SEK
2006-04-21 Ordinarie utdelning GETI B 2.00 SEK
2005-04-20 Ordinarie utdelning GETI B 1.65 SEK
2004-04-22 Ordinarie utdelning GETI B 1.35 SEK
2003-11-25 Split GETI B 1:4
2003-04-24 Ordinarie utdelning GETI B 4.25 SEK
2002-04-19 Ordinarie utdelning GETI B 3.75 SEK
2001-04-24 Ordinarie utdelning GETI B 3.50 SEK
2000-04-28 Ordinarie utdelning GETI B 3.50 SEK
1999-04-22 Ordinarie utdelning GETI B 3.25 SEK
1998-04-24 Ordinarie utdelning GETI B 2.75 SEK
1997-04-30 Ordinarie utdelning GETI B 2.50 SEK
1996-04-19 Ordinarie utdelning GETI B 6.00 SEK

Beskrivning

LandSverige
ListaLarge Cap Stockholm
SektorHälsovård
IndustriMedicinteknik
Getinge är en global leverantör av tekniska lösningar för sjukvårdsindustrin. Bolaget är en utvecklare samt tillverkare av lösningar som används inom operationssalar, intensivvårdsenheter och sterilcentraler. Bolagets produkter används exempelvis för infektionskontroll, bland IT-system, patienthantering, samt vid vård av kraftigt överviktiga patienter. Huvudkontoret ligger i Göteborg.
2022-07-19 08:00:00

"Order intake and net sales declined organically by 5% and 7.5% respectively in the quarter, which however ended with increased order intake," says Mattias Perjos, President & CEO. "Our customers are planning for a normal flu season in the second half of the year, which is expected to result in a recovery in ICU products".

The performance for the quarter as a whole was impacted by reduced production of COVID-19 vaccines and the number of patients requiring life support in Intensive Care Units (ICUs) declining significantly more than both the health care sector and Getinge had predicted, combined with a milder flu season. In addition, Getinge was impacted negatively by the Russian invasion of Ukraine, lockdowns in China and supply chain challenges.

"Acute Care Therapies decreased its net sales organically, while both Life Science and Surgical Workflows grew," says Mattias Perjos, President & CEO. "Net sales increased in products for elective cardiovascular procedures, infrastructure for ORs and sterile supply departments in hospitals and products for drug manufacturing".

During the quarter, Getinge completed an internal investigation related to potential violations of German Medical Device Act. Five current and former Getinge employees are being investigated for these potential violations by the public prosecution office in Germany. The company is cooperating fully with the prosecution office and its internal investigation identified shortcomings regarding individual interpretations of quality and regulatory processes. In addition to the comprehensive remediation measures already in place, Getinge is also making structural changes and has identified training measures.

Getinge noted favorable currency effects on earnings in the quarter, but margins remained intact even excluding this, given lower volumes, unfavorable mix effects and negative effects from supply chain challenges.

April - June 2022 in brief
  • Net sales declined organically by 7.5% and the order intake declined organically by 5.0%.
  • Adjusted gross profit amounted to SEK 3,355 M (3,624) and the margin was 50.3% (55.0).
  • Adjusted EBITA amounted to SEK 956 M (1,250) and the margin was 14.3% (19.0).
  • Adjusted earnings per share amounted to SEK 2.33 (3.04).
  • Cash flow after net investments amounted to SEK 129 M (1,228).
  • Changes to Getinge Executive Team: Lena Hagman will leave Getinge and her role as EVP Quality Compliance, Regulatory & Medical Affairs by the end of the year at the latest. On July 14, Agneta Palmér was appointed EVP Operational Services. She will take up the position on September 15.

Phone Conference

A conference call will be held on July 19, 2022, at 10:00-11:00 am CEST hosted by Mattias Perjos, President & CEO, and Lars Sandström, CFO. Please see dial in details below to join the conference:

SE: +46-8-5051-6386
UK: +44-20-319-84884
US: +1-412-317-6300
Use the following pin code: 1863734#

During the conference call a presentation will be held. To access the presentation through webcast, please use this link: https://tv.streamfabriken.com/getinge-q2-2022

Alternatively, use the following link to download the presentation: https://www.getinge.com/int/about-us/investors/reports-presentations/

Agenda
09:45    Dial in to the conference
10:00    Presentation
10:30    Q&A
11:00    End of conference

Recording available for 3 years
A recorded version can be accessed for 3 years via https://tv.streamfabriken.com/getinge-q2-2022  

Media contact:

Lars Mattson, Head of Investor Relations
Tel: +46 (0)10 335 0043
Email: lars.mattsson@getinge.com
 

This information is such that Getinge AB is obliged to make public pursuant to the EU Market Abuse Regulation and the Swedish Securities Market Act. The information was submitted for publication, through the agency of the contact person set out above, on July 19, 2022, at 08:00 a.m. CEST.

About Getinge

With a firm belief that every person and community should have access to the best possible care, Getinge provides hospitals and life science institutions with products and solutions that aim to improve clinical results and optimize workflows. The offering includes products and solutions for intensive care, cardiovascular procedures, operating rooms, sterile reprocessing and life science. Getinge employs over 10,000 people worldwide and the products are sold in more than 135 countries.